期刊文献+

临床药师参与1例脑出血合并静脉血栓栓塞症患者的药学监护

Pharmaceutical Care for One Patient with Tracerebral Hemorrhage Complicated with Venous Thromboembolism
下载PDF
导出
摘要 探讨临床药师在脑出血合并静脉血栓栓塞症(VTE)患者的药物治疗中的作用。临床药师对降压药物、抗凝药物使用及药物不良反应等方面全程实施药学监护,向医师提出合理建议,在参与患者诊疗过程中,从药学角度协助医师优化用药方案,能一定程度提高临床疗效,改善了临床用药的合理性。 The role of clinical pharmacists in the treatment of patients with tracerebral hemorrhage complicatd with venous thromboembolism(VTE)was discussed.The whole course of drug monitoring for antihypertensives,anticoagulant agents and adverse drug reactions were analyzed.Clinical pharmacists put forward reasonable suggestions for drug use,participated in the diagnosis and treatment of the patient and improved the clinical efficacy.The curative effect was also improved to a certain extent,as well as the rationality of clinical medication.
作者 叶陈丽 宋芳 张友恒 曹伟灵 Ye Chenli;Song Fang;Zhang Youheng;Cao Weiling(Department of Pharmacy,Shenzhen Luohu District People’s Hospital,Guangdong Shenzhen 518000,China)
出处 《中国药师》 CAS 2020年第9期1768-1771,共4页 China Pharmacist
基金 2019年深圳市罗湖区科技创新局软科学研究计划(编号:LX20190902)。
关键词 临床药师 脑出血 静脉血栓栓塞症 药学监护 Clinical pharmacists Tracerebral hemorrhage Venous thromboembolism Pharmaceutical care
  • 相关文献

参考文献6

二级参考文献75

  • 1周自强,胡大一,陈捷,张仁汉,李奎宝,赵秀丽.中国心房颤动现状的流行病学研究[J].中华内科杂志,2004,43(7):491-494. 被引量:1401
  • 2国家"十五"攻关"肺栓塞规范化诊治方法的研究"课题组,杨媛华,翟振国,武燕兵,王辰.急性肺血栓栓塞症患者516例临床表现分析[J].中华医学杂志,2006,86(31):2161-2165. 被引量:79
  • 3陆芸,马宝通,郭若霖,张建国,吴英华,庞贵根,辛景义,叶伟胜,邹玉安,王毅,董强,王学谦,Kerry H,Paul C,John F.骨科创伤患者深静脉血栓危险因素的研究[J].中华骨科杂志,2007,27(9):693-698. 被引量:244
  • 4Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as anindependent risk factor for stroke : the Framingham Study. Stroke,1991,22:983-988.
  • 5Xu G, Liu X,Wu W, et al. Recurrence after ischemic stroke inChinese patients : impact of uncontrolled modifiable risk factors.Cerebrovasc Dis,2007 ,23 : 117-120.
  • 6Lansberg MG, O'Donnell MJ, Khatri P,et al. Antithrombotic andthrombolytic therapy for ischemic stroke : Antithrombotic Therapyand Prevention of Thrombosis, 9th ed : American College of ChestPhysicians Evidence-Based Clinical Practice Guidelines. Chest,2012,141(2 Suppl) : e601S-636S.
  • 7Camm AJ, Lip GY, De Caterina R, et al. 2012 focused update ofthe ESC Guidelines for the management of atrial fibrillation : anupdate of the 2010 ESC Guidelines for the management of atrialfibrillation-developed with the special contribution of the EuropeanHeart Rhythm Association. Europace, 2012 ,14 : 1385-1413.
  • 8McCart GM, Kayser SR. Therapeutic equivalency of low-molecular-weight heparins. Ann Pharmacother, 2002 , 36: 1042-1057.
  • 9Ieko M , Tarumi T, Takeda M, et al. Synthetic selective inhibitorsof coagulation factor X a strongly inhibit thrombin generationwithout affecting initial thrombin forming time necessary for plateletactivation in hemostasis. J Thromb Haemost, 2004,2:612-618.
  • 10Turpie AG. Oral,direct factor X a inhibitors in development forthe prevention and treatment of thromboembolic diseases.Arterioscler Thromb Vase Biol, 2007 , 27 :1238-1247.

共引文献3757

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部